RxDoctor Payments Data

Martha Pickard

Adult Health · Lakeland, FLNPI 1245536770

Payments from drug & device makers

$3,118in general payments, 2019–2025

Across 78 payments — averaging $39.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Axonics, Inc.$2K
  • Coloplast$546
  • Astellas Pharma US Inc$168
  • Pfizer$147
  • Endo Pharmaceuticals Inc.$139
  • Medtronic$118
  • plus $486 from 14 others

What the payments were for

  • Travel & lodging$1,26441%
  • Food & beverage$1,77057%
  • Education$853%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,118 in reported general payments places this provider in the 80th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$81,114
Medicare patients
533
Services billed
1,239

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron185$124,569
GemtesaVibegron130$98,797
Mirabegron ErMirabegron22$15,217
Tamsulosin Hcl734$9,895
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst162$6,083
Trimethoprim107$5,725
Methenamine Hippurate25$3,683
Finasteride287$3,380
NitrofurantoinNitrofurantoin Macrocrystal73$2,973
Tadalafil13$2,617
Solifenacin Succinate65$2,284
Oxybutynin Chloride ErOxybutynin Chloride65$1,706
Testosterone Cypionate60$1,672
Cephalexin87$1,633
Dutasteride26$1,440

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$168$124,569185 claims
Sumitomo Pharma America, Inc.Gemtesa$16$98,797130 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,237 adult health providers in Florida.

Other adult health in Lakeland

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →